Keywords
Bleomycin
Basal cell carcinoma
Squamous cell carcinoma
Non-melanoma skin cancer
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To conduct a bibliometric analysis on the topic of the drug bleomycin and its use in the treatment of basal cell carcinoma and squamous cell carcinoma, which represent 95% of non-melanoma skin cancers. Methods: For this purpose, the Web of Science database was used in this study, with a time frame from 2001 to 2023, resulting in 407 documents analyzed. Results: The results presented showed that the topic is omnipresent in all years analyzed, that there is a diversity of authors, as well as prominent authors. Regarding scientific journals, the characteristics of those that publish the most varied were different, with journals exclusively focused on the topic of cancer, urology, and gynecology. The most frequently used keywords highlighted the form of treatment, the type of cancer, and drugs. Final considerations: It was found that the topic is prominent and that there is a trend for research on bleomycin and skin cancer to continue to be published.
References
ALAM M, RATNER D. Cutaneous Squamous-Cell Carcinoma. The new England Journal of Medicine, 2001; 344(13): 975-983.
BARROS AJP, LEHFELD NAS. Fundamentos de metodologia: um guia para a iniciação científica. São Paulo: McGraw-Hill, 1986. 91p.
BERTINO G, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer. European Journal of Cancer, 2016; 63: 41-52.
BIK L, et al. Efficacy and tolerability of intralesional bleomycin in dermatology: A systematic review. Journal of the American Academy of Dermatology, 2020; 83(3): 888-903.
CERVO AL, et al. Metodologia Científica. 6. ed. São Paulo: Pearson, 2007.60 e 63p.
CHINEM VP, MIOT HA. Epidemiologia do carcinoma basocelular. Anais Brasileiros de Dermatologia, 2011: 86(2): 292–305.
CLOVER AJP, et al. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up. European Journal of Surgical Oncology, 2020; 46(5): 847-854.
DE GIORGI V, et al. The use of cisplatin electrochemotherapy in nonmelanoma skin cancers: A single‐center study. Dermatologic Therapy, 2020; 33(4): e13547.
FERREIRA JB, et al. Diversidade e gênero no contexto organizacional: um estudo bibliométrico. Revista Pensamento Contemporâneo, 2015; 9(3): 45-66.
GEHL J, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncologica, 2018 ;57(7): 874-882.
GOTHELF A, et al. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treatment Reviews, 2003; 29(5): 371-387.
GUEDES VLS. A bibliometria e a gestão da informação e do conhecimento científico e tecnológico: uma revisão da literatura. Ponto de Acesso, 2012; 6(2): 74-109.
HARRINGTON KJ, et al. Effective Targeting of Solid Tumors in Patients With Locally Advanced Cancers by Radiolabeled Pegylated Liposomes. Clinical Cancer Research, 2001; 7(2): 243-254.
INSTITUTO NACIONAL DE CÂNCER - INCA. ABC do câncer: abordagens básicas para o controle do câncer. Instituto Nacional do Câncer: Rio de Janeiro, 2012. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/inca/abc_do_cancer_2ed.pdf. Acesso em: 29 out. 2025.
INSTITUTO NACIONAL DE CÂNCER - INCA. Câncer de pele não melanoma. 2022. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/tipos/pele-nao-melanoma. Acesso em: 29 out. 2025.
MALI B, et al. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. European Journal of Surgical Oncology, 2013; 39(1): 4-16.
MICHEL MH. Metodologia e pesquisa científica em Ciências Sociais: um guia prático para acompanhamento da disciplina e elaboração de trabalhos monográficos. 2. ed. São Paulo: Atlas, 2009. 37p.
NATIONAL LIBRARY OF MEDICINE - PUBCHEM (United States). Bleomycin. 2005. Disponível em: https://pubchem.ncbi.nlm.nih.gov/compound/Bleomycin. Acesso em 28 ago. 2023.
PACOLA PR, et al. Chemotherapeutical treatment of basal cell carcinoma with bleomycin via microinfusion of the drug into the skin (MMP®). Anais Brasileiros de Dermatologia, 2023; 98(5): 587-594.
PATEL RV, et al. An Update on Nonmelanoma Skin Cancer. Journal of Clinical and Aesthetic Demartology. 2011; 4(2): 20-27.
PRIETO-GRANADA C, RODRIGUEZ-WAITKUS P. Basal cell carcinoma: Epidemiology, clinical and histologic features, and basic science overview. Current Problems in Cancer, 2015; 39(4): 198-205.
SAITTA P, et al. Bleomycin in Dermatology: A Review of Intralesional Applications: Bleomycin in dermatology. Dermatologic Surgery, 2008; 34(10): 1299-1313.
SANTOS MO, et al. Estimativa de Incidência de Câncer no Brasil, 2023-2025. Revista Brasileira de Cancerologia, 2023; 69(1): e-213700.
UMEZAWA H, et al. New antibiotics, bleomycin A and B. The Journal of Antibiot, 1966; 19(5): 200-209.